Criteria for treatment response as assessed after (or within) 6 courses
. | Criterion . |
---|---|
Clinical remission | |
Lymph node, spleen, and liver enlargement (clinical) | Absent |
Lymphocytosis | < 4.109/L |
Neutrophils | ≥ 1.5 109/L |
Platelets | ≥ 100 109/L |
Hemoglobin level | ≥ 110 g/L |
Partial remission | |
Decrease in lymph node, spleen, and liver enlargement | > 50% |
Decrease in lymphocytosis | > 50% from baseline value |
Neutrophils | > 1.5 109/L or increased by 50% from baseline value |
Platelets | > 100 109/L or increased by 50% from baseline value |
Hemoglobin level | > 110 g/L or increased by 50% from baseline value |
Stable disease | |
Response or progression | Absent |
Progressive disease | |
Increase in lymph node, spleen, or liver volume | > 50% or new involvement of these organs |
Increase in lymphocytosis | > 50% from baseline value |
Neutrophils | < 1.5 109/L or decreased by 50% from baseline value |
Platelets | < 100 109/L or decreased by 50% from baseline value |
Hemoglobin level | < 110 g/L or decreased by 50% from baseline value |
. | Criterion . |
---|---|
Clinical remission | |
Lymph node, spleen, and liver enlargement (clinical) | Absent |
Lymphocytosis | < 4.109/L |
Neutrophils | ≥ 1.5 109/L |
Platelets | ≥ 100 109/L |
Hemoglobin level | ≥ 110 g/L |
Partial remission | |
Decrease in lymph node, spleen, and liver enlargement | > 50% |
Decrease in lymphocytosis | > 50% from baseline value |
Neutrophils | > 1.5 109/L or increased by 50% from baseline value |
Platelets | > 100 109/L or increased by 50% from baseline value |
Hemoglobin level | > 110 g/L or increased by 50% from baseline value |
Stable disease | |
Response or progression | Absent |
Progressive disease | |
Increase in lymph node, spleen, or liver volume | > 50% or new involvement of these organs |
Increase in lymphocytosis | > 50% from baseline value |
Neutrophils | < 1.5 109/L or decreased by 50% from baseline value |
Platelets | < 100 109/L or decreased by 50% from baseline value |
Hemoglobin level | < 110 g/L or decreased by 50% from baseline value |